1. FDA grants Bristol-Myers priority review for ide-cel — Is Illumina making an $8B blunder? — Medicare may not cover the cost of the coronavirus vaccine — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Leadership

Discussion in 'GI Path' started by Anonymous, Mar 2, 2015 at 3:04 PM.

  1. Anonymous

    Anonymous Guest

    No volume and sales sucks! Can you lead a company from the golf course?
     
  2. Anonymous

    Anonymous Guest

    and also be screwing an employee too. sad
     
  3. anonymous

    anonymous Guest

    Who is it this time?
     
  4. anonymous

    anonymous Guest

    Very reliable source has GI Path (aka Pooplar) going out of business very soon. Nice work JS. Time to hit the golf course
     
  5. anonymous

    anonymous Guest

    Four
     
  6. anonymous

    anonymous Guest

    whatever happened to BM?